ANTIBODY DRUG CONJUGATES SUMMIT 2019

December 4-5, 2019 | Austria

The summit will shed light on how ADCs and novel bioconjugates development can be optimised for the future. ... We are pleased to invite you to the 4th Annual Antibody Drug Conjugates Summit: From Target to Therapeutics scheduled

Spotlight

This report exposes the excessive lobbying influence of the pharmaceutical industry on EU decision-making. Big pharma enjoys semi-systematic privileged access to decision-making in Brussels, facilitated by its vast lobby expenditure, complex web of actors, extensive meetings with policy-makers, and participation in advisory groups.


OTHER PAST CONFERENCES

East West BioPharma Summit

November 14-16, 2022 | USA

BioCentury and BayHelix invite you to Register Now to join us at the East-West BioPharma Summit at the Grand Bay Hotel San Francisco, Redwood City, CA on Nov. 14-16, 2022.

REIMAGINING THE MEETING PLANNING EXPERIENCE IN LIFE SCIENCES

September 11-14, 2022 | USA

Pharma Forum is the largest, most influential conference for Meeting & Event Professionals to navigate the future of medical meetings, address compliance implications and execute contracting strategies with virtual, hybrid, and face-to-face.

Future Lab Informatics 2022

November 15-17, 2022 | USA

The global laboratory informatics market is forecast to reach $3.8bn by 2024, with the growth driven primarily by the enhanced importance of data analytics for drug discovery.

Pharma 2022

October 11-13, 2022 | France

Comprehensive frameworks for equitable access and accelerated digital transformations are soon to be realized. But progress is slowing, risking a return to the old model plagued by persistent health disparities.

Spotlight

This report exposes the excessive lobbying influence of the pharmaceutical industry on EU decision-making. Big pharma enjoys semi-systematic privileged access to decision-making in Brussels, facilitated by its vast lobby expenditure, complex web of actors, extensive meetings with policy-makers, and participation in advisory groups.

resources